Severe Acquired Factor VIII Deficiency With Concomitant Lupus Anticoagulant: A Case Report.

Authors

Tae Hoon Kim, Ammar Khawar, Jason Suh

Published in

Cureus. Volume 18. Issue 7. Pages e113229. Epub Jul 23, 2026.

Abstract

Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder caused by autoantibodies against factor VIII (F VIII). The coexistence of AHA with lupus anticoagulant (LAC) is incredibly uncommon and presents a significant diagnostic challenge, as both conditions prolong activated partial thromboplastin time (aPTT) and demonstrate incomplete correction on mixing studies. We report a case of a 79-year-old man with no prior bleeding history who presented with severe anemia and a retroperitoneal hematoma following a fall. Laboratory evaluation revealed markedly prolonged aPTT, severely reduced F VIII activity (<7%), and an exceptionally elevated inhibitor titer (1084 Bethesda units), consistent with AHA. Concurrently, anticoagulant testing was done with a positive LAC presence. Extensive workup failed to identify an underlying etiology. The patient was subsequently treated with rituximab and corticosteroids, resulting in a gradual decline in aPTT and inhibitor titers with clinical improvement. This case highlights the importance of comprehensive coagulation testing in patients with unexplained bleeding and prolonged aPTT, as the coexistence of prothrombotic and hemorrhagic conditions can obscure diagnosis and delay appropriate management.

PMID:
42633399
Bibliographic data and abstract were imported from PubMed on 23 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.